BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17404022)

  • 1. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.
    Koda M; Sulkowska M; Wincewicz A; Kanczuga-Koda L; Musiatowicz B; Szymanska M; Sulkowski S
    Ann N Y Acad Sci; 2007 Jan; 1095():90-8. PubMed ID: 17404022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Cascio S; Colucci G; Russo A; Surmacz E; Sulkowski S
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi116-9. PubMed ID: 17591803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.
    Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    Tissue Cell; 2008 Dec; 40(6):405-10. PubMed ID: 18579174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
    Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
    BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells.
    Ren H; Jia L; Zhao T; Zhang H; Chen J; Yang S; Liu J; Yu M; Hao J
    Cancer Lett; 2014 Nov; 354(1):172-80. PubMed ID: 25130171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.
    Garofalo C; Koda M; Cascio S; Sulkowska M; Kanczuga-Koda L; Golaszewska J; Russo A; Sulkowski S; Surmacz E
    Clin Cancer Res; 2006 Mar; 12(5):1447-53. PubMed ID: 16533767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis between the expressions of leptin and its receptor (ObR) and clinicopathology in endometrial cancer.
    Zhang Y; Liu L; Li C; Ai H
    Cancer Biomark; 2014; 14(5):353-9. PubMed ID: 25171477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia contributes to development of recurrent endometrial carcinoma.
    Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
    Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas.
    Bogusiewicz M; Semczuk A; Gogacz M; Skomra D; Jakowicki JA; Rechberger T
    Cancer Lett; 2006 Jul; 238(1):61-8. PubMed ID: 16085355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
    Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
    Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level.
    Liao Y; Lu W; Che Q; Yang T; Qiu H; Zhang H; He X; Wang J; Qiu M; Zou Y; Gu W; Wan X
    PLoS One; 2014; 9(6):e99907. PubMed ID: 24918449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression and possible involvement of the leptin receptor in endometrial cancer.
    Yuan SS; Tsai KB; Chung YF; Chan TF; Yeh YT; Tsai LY; Su JH
    Gynecol Oncol; 2004 Mar; 92(3):769-75. PubMed ID: 14984939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer.
    Ishikawa M; Kitayama J; Nagawa H
    Clin Cancer Res; 2004 Jul; 10(13):4325-31. PubMed ID: 15240518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
    Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
    Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
    Badowska-Kozakiewicz A; Sobol M; Patera J
    Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.
    Berg A; Fasmer KE; Mauland KK; Ytre-Hauge S; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Woie K; Bjørge L; Bjørnerud A; Salvesen HB; Werner HM; Krakstad C; Haldorsen IS
    Oncotarget; 2016 Oct; 7(43):69844-69856. PubMed ID: 27634881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced factor-1α in endometrial carcinoma: a mini-review of current evidence.
    Dousias V; Vrekoussis T; Navrozoglou I; Paschopoulos M; Stefos T; Makrigiannakis A; Jeschke U
    Histol Histopathol; 2012 Oct; 27(10):1247-53. PubMed ID: 22936443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
    Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
    BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.